UK Companies House feature
CATALENT MTI PHARMA SOLUTIONS LIMITED
Profile
- Company number
- 08338674
- Status
- Active
- Incorporation
- 2012-12-20
- Last accounts made up
- 2024-06-30
- Account category
- FULL
- Primary SIC
- 21100
- Hubs
- UK Healthcare
Accounts
Pending extraction
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Grant Thornton UK LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Directors have assessed the going concern of the legal entity through to 30 June 2026. The company has limited activity and has limited cash flows outside of the Catalent Inc ("Catalent") group. It is in a net current liabilities position as of 30 June 2024 and is therefore reliant on the support of Catalent to satisfy the going concern assumption. The company has received a support letter from Catalent Inc which confirms that Catalent Inc will assist the company in meeting its liabilities as and when they fall due, but only to the extent that money is not otherwise available to it to meet such liabilities, and has confirmed that it has the ability to provide such support throughout the going concern period to 30 June 2026. Having assessed the responses of the management of Catalent Inc, to their enquiries, the directors have no reason to believe that a material uncertainty exists that may cast significant doubt on the ability of the Catalent group to continue as a going concern and therefore to continue to provide support to the entity as and when it is required.”
Subsidiaries
- Catalent Micron Technologies Limited · 100% held · England · provision of contract particle size reduction services to the pharmaceutical industry
Significant events
- “On 5th February 2024, the ultimate parent, Catalent Inc., announced its merger agreement with Novo Holdings Limited, under which Novo Holdings Limited would acquire Catalent Inc. in an all-cash transaction. The acquisition by Novo Holdings Limited was completed on 18th December 2024 after satisfying customary closing conditions, including approval by Catalent Inc. stockholders and receipt of required regulatory approvals.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 18 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CERON, Ramon Javier, Mr. | Director | 2025-08-29 | Aug 1969 | American |
| ELIA, Giuseppe, Mr. | Director | 2025-11-12 | Feb 1981 | British |
| HOPSON, Ricky, Mr. | Director | 2025-08-29 | Jun 1975 | American |
Show 18 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| FORDE, Nyssa | Secretary | 2018-03-29 | 2024-10-22 |
| HUNEAU, Jeremy | Secretary | 2015-12-16 | 2016-05-06 |
| JOSEPH, Wetteny | Secretary | 2014-11-13 | 2015-12-16 |
| ALTMAN, Matthew Laurence | Director | 2012-12-20 | 2014-11-13 |
| ARNOLD, Jonathan | Director | 2018-03-29 | 2022-09-14 |
| CASTELLANO, Tom | Director | 2021-06-03 | 2022-09-14 |
| DROST, Joseph David, Ceo | Director | 2013-03-11 | 2014-11-13 |
| FASMAN, Steven | Director | 2014-11-13 | 2023-09-13 |
| HAWKESWOOD, Thomas | Director | 2022-09-14 | 2025-09-29 |
| HOULTON, Scott | Director | 2014-11-13 | 2015-12-14 |
| JOSEPH, Wetteny | Director | 2018-03-29 | 2021-06-03 |
| KEANE, James | Director | 2024-02-01 | 2025-11-12 |
| LARRAN, Jean Martin | Director | 2013-03-11 | 2014-11-13 |
| LITTLEJOHNS, Barry | Director | 2015-12-14 | 2018-03-29 |
| MANOS, Peter | Director | 2013-03-11 | 2014-11-13 |
| SWANSTON, Philip | Director | 2022-09-14 | 2024-01-05 |
| WALSH, Mattew, Dr | Director | 2014-11-13 | 2018-03-29 |
| WODLINGER, David, Director Board Of Directors | Director | 2013-03-11 | 2014-11-13 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Catalent, Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2020-04-23 | Active |
Filing timeline
Last 20 of 87 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-03-16 | AP01 | officers | appoint person director company with name date |
| 2026-01-16 | CS01 | confirmation-statement | confirmation statement with updates |
| 2026-01-09 | AP01 | officers | appoint person director company with name date |
| 2026-01-09 | AP01 | officers | appoint person director company with name date |
| 2025-11-20 | TM01 | officers | termination director company with name termination date |
| 2025-11-20 | TM01 | officers | termination director company with name termination date |
| 2025-06-13 | AA | accounts | accounts with accounts type full |
| 2025-02-24 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-01-13 | AA01 | accounts | change account reference date company current extended |
| 2024-10-22 | TM02 | officers | termination secretary company with name termination date |
| 2024-06-05 | AA | accounts | accounts with accounts type full |
| 2024-02-05 | AP01 | officers | appoint person director company with name date |
| 2024-01-16 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-01-11 | TM01 | officers | termination director company with name termination date |
| 2023-12-06 | TM01 | officers | termination director company with name termination date |
| 2023-07-19 | AA | accounts | accounts with accounts type full |
| 2023-01-16 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-11-01 | AP01 | officers | appoint person director company with name date |
| 2022-10-31 | AP01 | officers | appoint person director company with name date |
| 2022-10-31 | TM01 | officers | termination director company with name termination date |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory